These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38131274)

  • 1. Natural products applied in acute kidney injury treatment: polymer matters.
    Yu B; Jin Q; Ji J
    Biomater Sci; 2024 Jan; 12(3):621-633. PubMed ID: 38131274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural ursolic acid based self-therapeutic polymer as nanocarrier to deliver natural resveratrol for natural therapy of acute kidney injury.
    Nie Y; Wang L; Liu S; Dai C; Cui T; Lei Y; You X; Wang X; Wu J; Zheng Z
    J Nanobiotechnology; 2023 Dec; 21(1):484. PubMed ID: 38105186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of curcumin in the treatment of acute kidney injury: research challenges and opportunities.
    Cai Y; Huang C; Zhou M; Xu S; Xie Y; Gao S; Yang Y; Deng Z; Zhang L; Shu J; Yan T; Wan CC
    Phytomedicine; 2022 Sep; 104():154306. PubMed ID: 35809376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney.
    Chen Q; Nan Y; Yang Y; Xiao Z; Liu M; Huang J; Xiang Y; Long X; Zhao T; Wang X; Huang Q; Ai K
    Bioact Mater; 2023 Apr; 22():141-167. PubMed ID: 36203963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney-Targeted Nanoparticles Loaded with the Natural Antioxidant Rosmarinic Acid for Acute Kidney Injury Treatment.
    Li J; Duan Q; Wei X; Wu J; Yang Q
    Small; 2022 Dec; 18(48):e2204388. PubMed ID: 36253133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-small natural product based coordination polymer nanodots for acute kidney injury relief.
    Zhang R; Cheng L; Dong Z; Hou L; Zhang S; Meng Z; Betzer O; Wang Y; Popovtzer R; Liu Z
    Mater Horiz; 2021 Apr; 8(4):1314-1322. PubMed ID: 34821924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidative 0-dimensional nanodrugs overcome obstacles in AKI antioxidant therapy.
    Yang Y; Nan Y; Chen Q; Xiao Z; Zhang Y; Zhang H; Huang Q; Ai K
    J Mater Chem B; 2023 Aug; 11(34):8081-8095. PubMed ID: 37540219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylenediamine-Based Carbon Nanodots Alleviate Acute Kidney Injury via Preferential Renal Accumulation and Antioxidant Capacity.
    Gao J; Liu Y; Jiang B; Cao W; Kan Y; Chen W; Ding M; Zhang G; Zhang B; Xi K; Jia X; Zhao X; Guo H
    ACS Appl Mater Interfaces; 2020 Jul; 12(28):31745-31756. PubMed ID: 32571010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis: A new mechanism of traditional Chinese medicine compounds for treating acute kidney injury.
    Shi Y; Shi X; Zhao M; Chang M; Ma S; Zhang Y
    Biomed Pharmacother; 2023 Jul; 163():114849. PubMed ID: 37172334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy.
    Dragojevic S; Ryu JS; Raucher D
    Molecules; 2015 Dec; 20(12):21750-69. PubMed ID: 26690101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormones for acute kidney injury.
    Nigwekar SU; Strippoli GF; Navaneethan SD
    Cochrane Database Syst Rev; 2013 Jan; (1):CD006740. PubMed ID: 23440810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
    Zhang X; Agborbesong E; Li X
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4: An attractive therapeutic target for acute kidney injury.
    Jha AK; Gairola S; Kundu S; Doye P; Syed AM; Ram C; Murty US; Naidu VGM; Sahu BD
    Life Sci; 2021 Apr; 271():119155. PubMed ID: 33548286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural products: potential treatments for cisplatin-induced nephrotoxicity.
    Fang CY; Lou DY; Zhou LQ; Wang JC; Yang B; He QJ; Wang JJ; Weng QJ
    Acta Pharmacol Sin; 2021 Dec; 42(12):1951-1969. PubMed ID: 33750909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in pharmacotherapy for acute kidney injury.
    Xu Y; Zou P; Cao X
    Expert Opin Pharmacother; 2022 Apr; 23(6):713-726. PubMed ID: 35287527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin and AKI: an ongoing battle with new perspectives-a narrative review.
    Volovat S; Apetrii M; Stefan A; Vlad C; Voroneanu L; Hogas M; Haisan A; Volovat C; Hogas S
    Int Urol Nephrol; 2023 May; 55(5):1205-1209. PubMed ID: 36508071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecules as a source for acute kidney injury therapy.
    Feng YL; Yang Y; Chen H
    Pharmacol Ther; 2022 Sep; 237():108169. PubMed ID: 35306111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria: a therapeutic target in acute kidney injury.
    Ishimoto Y; Inagi R
    Nephrol Dial Transplant; 2016 Jul; 31(7):1062-9. PubMed ID: 26333547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed treatment with PTBA analogs reduces postinjury renal fibrosis after kidney injury.
    Skrypnyk NI; Sanker S; Skvarca LB; Novitskaya T; Woods C; Chiba T; Patel K; Goldberg ND; McDermott L; Vinson PN; Calcutt MW; Huryn DM; Vernetti LA; Vogt A; Hukriede NA; de Caestecker MP
    Am J Physiol Renal Physiol; 2016 Apr; 310(8):F705-F716. PubMed ID: 26661656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutraceuticals and network pharmacology approach for acute kidney injury: A review from the drug discovery aspect.
    Dagar N; Kale A; Jadhav HR; Gaikwad AB
    Fitoterapia; 2023 Jul; 168():105563. PubMed ID: 37295755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.